Verona Pharma plc (NASDAQ:VRNA) Q4 2022 Earnings Conference Call March 7, 2023 9:00 AM ET Company Participants David Zaccardelli - President and Chief Executive Officer Mark Hahn - Chief Financial Officer Kathleen Rickard - Chief Medical Officer Christopher Martin - Senior Vice President Commercial Conference Call Participants Andreas Argyrides - Wedbush Joon Lee - Truist Securities Thomas Shrader - BTIG Boobalan Pachaiyappan - H.C. Wainwright Operator Welcome to Verona Pharma's, Fourth Quarter and Full Yea ...

Developing innovative therapies for the treatment of respiratory diseases March 2023 Breath of Innovation™ Nasdaq: VRNA | www.veronapharma.com Forward-looking statements This presentation contains "forward‐looking" statements that are based on the beliefs and assumptions and on information currently available to management of Verona Pharma plc (together with its consolidated subsidiaries, the "Company"). All statements other than statements of historical fact contained in this presentation are forward-looki ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM __________ TO __________ Commission File Number: 001-38067 Verona Pharma plc (Exact name of Registrant as specified in its Charter) United Kingdom 98-1489389 (State or other ...

Verona Pharma plc (NASDAQ:VRNA) Q3 2022 Earnings Conference Call November 9, 2022 9:00 AM ET Company Participants David Zaccardelli – Chief Executive Officer Mark Hahn – Chief Financial Officer Kathy Rickard – Chief Medical Officer Chris Martin – Senior Vice President-Commercial Conference Call Participants Suji Jeong – Jefferies Boobalan Pachaiyappan – H.C. Wainwright Tom Shrader – BTIG Operator Welcome to Verona Pharma's, Third Quarter 2022 Financial Results and Operating Highlights Conference Call. At th ...

ENHANCE-2 Phase 3 data August 2022 Nasdaq: VRNA | www.veronapharma.com Forward-looking statements This presentation contains "forward‐looking" statements that are based on the beliefs and assumptions and on information currently available to management of Verona Pharma plc (together with its consolidated subsidiaries, the "Company"). All statements other than statements of historical fact contained in this presentation are forward-looking statements. Forward‐looking statements include information concerning ...

Developing innovative therapies for the treatment of respiratory diseases March 2022 Breath of Innovation™ Nasdaq: VRNA | www.veronapharma.com Forward-looking statements This presentation contains "forward‐looking" statements that are based on the beliefs and assumptions and on information currently available to management of Verona Pharma plc (together with its consolidated subsidiaries, the "Company"). All statements other than statements of historical fact contained in this presentation are forward-looki ...

Verona Pharma plc (NASDAQ:VRNA) Q1 2022 Earnings Conference Call May 3, 2022 9:00 AM ET Company Representatives Dr. David Zaccardelli - Chief Executive Officer Mark Hahn - Chief Financial Officer Dr. Kathy Rickard - Chief Medical Officer Chris Martin - Senior Vice President of Commercial Conference Call Participants Suji Jeong - Jefferies Andreas Argyrides - Wedbush Securities Boobalan Pachaiyappan - H.C. Wainwright Edward Nash - Canaccord Genuity Joon Lee - Truist Securities Operator Welcome to Verona Phar ...

Developing innovative therapies for the treatment of respiratory diseases March 2022 Breath of Innovation™ Nasdaq: VRNA | www.veronapharma.com Forward-looking statements This presentation contains "forward‐looking" statements that are based on the beliefs and assumptions and on information currently available to management of Verona Pharma plc (together with its consolidated subsidiaries, the "Company"). All statements other than statements of historical fact contained in this presentation are forward-looki ...

Call Start: 09:00 January 1, 0000 9:33 AM ET Verona Pharma plc (NASDAQ:VRNA) Q4 2021 Earnings Conference Call March 3, 2022 09:00 ET Company Participants David Zaccardelli - President & Chief Executive Officer Mark Hahn - Chief Financial Officer Chris Martin - Senior Vice President of Commercial Kathleen Rickard - Chief Medical Officer Conference Call Participants Andreas Argyrides - Wedbush Securities Suji Jeong - Jefferies Tom Shrader - BTIG Operator Welcome to Verona Pharma's Fourth Quarter and Year End ...

Verona Pharma plc (NASDAQ:VRNA) Q3 2021 Earnings Conference Call November 9, 2021 9:00 AM ET Company Participants David Zaccardelli - President and Chief Executive Officer Mark Hahn - Chief Financial Officer Kathy Rickard - Chief Medical Officer Conference Call Participants Andreas Argyrides - Wedbush Securities Boobalan Pachaiyappan - H.C. Wainwright Tom Shrader - BTIG Operator Welcome to Verona Pharma's Third Quarter 2021 Financial Results and Operating Highlights Conference Call. At this time, all partic ...